A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

NCT00673556 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG: alefacept
DRUG: placebo

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]